Inventor · disambiguated record
Teresa Leah Wright
Also filed as: WRIGHT TERESA · WRIGHT TERESA L · WRIGHT TERESA LEAH
13 granted patents·9 pending applications·112 citations·filing 2011–2025
92Inventor score
Files withSHIRE HUMAN GENETIC THERAPIES10TAKEDA PHARMACEUTICALS CO6GENERATION BIO CO2CALIAS PERICLES1HOMOLOGY MEDICINES INC1
Top patents by PatentIndex Score
22 records- 0193US2025161417A1Methods and compositions for cns delivery of arylsulfatase aTAKEDA PHARMACEUTICALS CO·Filed 2024·Application pending·0 cites
- 0293US2025121040A1Methods and compositions for cns delivery of iduronate-2-sulfataseTAKEDA PHARMACEUTICALS CO·Filed 2024·Application pending·0 cites
- 0392US9220677B2Methods and compositions for CNS delivery of iduronate-2-sulfataseSHIRE HUMAN GENETIC THERAPIES·Filed 2013·Granted Dec 29, 2015·16 cites·27 claims
- 0492US8545837B2Methods and compositions for CNS delivery of iduronate-2-sulfataseZHU GAOZHONG·Filed 2011·Granted Oct 1, 2013·38 cites·30 claims
- 0592US2025375506A1Cns delivery of therapeutic agentsTAKEDA PHARMACEUTICALS CO·Filed 2025·Application pending·0 cites
- 0691US10456454B2CNS delivery of therapeutic agentsSHIRE HUMAN GENETIC THERAPIES·Filed 2016·Granted Oct 29, 2019·6 cites·27 claims
- 0791US9283181B2CNS delivery of therapeutic agentsCALIAS PERICLES·Filed 2011·Granted Mar 15, 2016·34 cites·6 claims
- 0890US10660944B2Stable formulations for CNS delivery of arylsulfatase ASHIRE HUMAN GENETIC THERAPIES·Filed 2018·Granted May 26, 2020·5 cites·23 claims
- 0989US11471516B2CNS delivery of therapeutic agentsSHIRE HUMAN GENETIC THERAPIES·Filed 2019·Granted Oct 18, 2022·1 cites·17 claims
- 1086US11260112B2Methods and compositions for CNS delivery of iduronate-2-sulfataseSHIRE HUMAN GENETIC THERAPIES·Filed 2019·Granted Mar 1, 2022·2 cites·17 claims
- 1185US12409210B2CNS delivery of therapeutic agentsTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Sep 9, 2025·0 cites·5 claims
- 1281US12121569B2Methods and compositions for CNS delivery of iduronate-2-sulfataseTAKEDA PHARMACEUTICALS CO·Filed 2022·Granted Oct 22, 2024·0 cites·15 claims
- 1380US9770410B2Methods and compositions for CNS delivery of arylsulfatase ASALAMAT-MILLER NAZILA·Filed 2011·Granted Sep 26, 2017·10 cites·32 claims
- 1475US12168041B2Methods and compositions for CNS delivery of arylsulfatase ATAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Dec 17, 2024·0 cites·6 claims
- 1573US10646554B2Methods and compositions for CNS delivery of arylsulfatase ASHIRE HUMAN GENETIC THERAPIES·Filed 2017·Granted May 12, 2020·0 cites·19 claims
- 1662US2016158324A1Methods and compositions for cns delivery of iduronate-2-sulfataseSHIRE HUMAN GENETIC THERAPIES·Filed 2015·Application pending·0 cites
- 1761US2020237883A1Stable formulations for cns delivery of arylsulfatase aSHIRE HUMAN GENETIC THERAPIES·Filed 2020·Application pending·0 cites
- 1859US2014377244A1Stable formulations for cns delivery of arylsulfatase aSHIRE HUMAN GENETIC THERAPIES·Filed 2012·Application pending·0 cites
- 1946US11952585B2Methods of treating phenylketonuriaHOMOLOGY MEDICINES INC·Filed 2021·Granted Apr 9, 2024·0 cites·17 claims
- 2044US2021059953A1Lipid nanoparticle formulations of non-viral, capsid-free dna vectorsGENERATION BIO CO·Filed 2018·Application pending·0 cites
- 2142US2020283794A1Modified closed-ended dna (cedna)GENERATION BIO CO·Filed 2018·Application pending·0 cites
- 2242US2016030416A1Methods of treating b2-bradykinin receptor mediated angioedemaSHIRE HUMAN GENETIC THERAPIES·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Teresa Leah Wright files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →